文献速递头颈部肿瘤放疗

高危头颈部肿瘤术后加速分割与常规分割辅助放疗的荟萃分析

Accelerated vs. conventionally fractionated adjuvant radiotherapy in high-risk head and neck cancer: a meta-analysis.
PubMed 文献 · Radiat Oncol · 2018-10-04

该荟萃分析纳入6项随机试验共988例局部晚期头颈部鳞状细胞癌(HNSCC)患者,比较加速分割与常规分割辅助放疗。

要点

  • 加速辅助放疗未显著改善高危HNSCC患者的局部区域控制、无进展生存或总生存。
  • 加速放疗组急性融合性黏膜炎发生率显著高于常规分割组。
  • 两组晚期副作用无显著差异。

核心结论

  • 加速放疗未显著改善高危患者的局部区域控制或总生存。
  • 加速放疗技术急性但非晚期放射性毒性更常见。
  • 在临床实践中,术后加速放疗可能仅适合部分患者。

研究设计与样本

  • 荟萃分析纳入6项随机试验,共988例局部晚期HNSCC患者随机接受加速或常规分割辅助放疗。
  • 从现有文献提取局部区域控制、远处转移及总生存、癌症特异性生存、无病生存的风险比(HR)。
  • 采用固定效应和随机效应模型进行效应量荟萃分析,并对急性和晚期副作用分类汇总比较。

主要发现

  • 加速放疗组急性融合性黏膜炎发生率显著更高。
  • 两组晚期副作用无显著差异。

临床怎么用

  • 在临床实践中,术后加速放疗可能仅适合部分患者(作者结论)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Adjuvant radiotherapy in advanced head and neck squamous cell cancer (HNSCC) reduces the risk of local-regional failure and most likely increases the survival rate. Patients at high risk for tumor recurrence may benefit from more aggressive altered fractionation schedules in order to reduce the overall time from surgery to completion of radiotherapy. Here, we reviewed the results of six randomized trials addressing the above hypothesis. METHODS: In the six trials of interest, a total of 988 patients with locally advanced HNSCC were randomly assigned to receive either accelerated or conventionally fractionated adjuvant radiotherapy. Hazard ratios (HR) were extracted from available publications for local-regional control, distant metastasis as well as overall-, cancer specific- and disease-free survival. Meta-analysis of the effect sizes was performed using fixed and random effect models. Acute and late side effects were categorized and summarized for comparison. RESULTS: Accelerated radiotherapy did not improve the loco-regional control (n = 988, HR = 0.740, CI = 0.48-1.13, p = 0.162), progression-free survival (HR = 0.89, CI = 0.76-1.04, p = 0.132) or overall survival (HR = 0.88, CI = 0.75-1.04, p = 0.148) significantly. Acute confluent mucositis occurred with significant higher frequency with accelerated radiotherapy. Late side effects did not differ significantly in either group. CONCLUSION: Accelerated radiotherapy does not result in a significant improvement of loco-regional control or overall survival in high-risk patients. Acute but not late radiation toxicity were more frequent with the accelerated RT technique. In clinical practice accelerated postoperative radiation therapy might be a suitable option only for a subset of patients.

来源:Radiat Oncol,查看原文。版权归原作者所有。

引用

  1. Matuschek C, Haussmann J, Bölke E, et al. Accelerated vs. conventionally fractionated adjuvant radiotherapy in high-risk head and neck cancer: a meta-analysis. Radiat Oncol. 2018. PMID: 30286777. doi:10.1186/s13014-018-1133-8

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。